RUS  ENG
Полная версия
ЖУРНАЛЫ // Mendeleev Communications // Архив

Mendeleev Commun., 2021, том 31, выпуск 6, страницы 865–866 (Mi mendc1069)

Эта публикация цитируется в 2 статьях

Communications

Anticancer activity of new benzofuroxan–imidazolone hybrids

E. A. Chugunovaa, A. V. Smolobochkina, A. S. Gazizova, A. R. Burilova, A. D. Voloshinaa, A. P. Lyubinaa, S. K. Amerhanovaa, T. A. Melnikovab, A. I. Tulesinovab, N. I. Akylbekovc, N. A. Akhatayevc, V. V. Syakaeva

a A.E. Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of the Russian Academy of Sciences, Kazan, Russian Federation
b Kazan National Research Technological University, Kazan, Russian Federation
c Korkyt Ata Kyzylorda University, Kyzylorda, Republic of Kazakhstan


Аннотация: Novel hybrid compounds containing both benzofuroxan and 1H-imidazol-2(3H)-one moieties were synthesized by an SNAr reaction between 7-chloro-4,6-dinitrobenzofuroxan and imidazol-2-ones, with the only C4 regioisomer having been formed. Cytotoxic effects of parent and obtained compounds were estimated on human cancer and normal cells, while two of imidazolones showed higher cytotoxicity in relation to the M-HeLa cancer line compared to the hybrid products. In relation to the normal liver cell line Chang, the tested compounds were found to be non-toxic and can be promising for further development of anticancer agents.

Ключевые слова: benzofuroxans, imidazol-2-ones, hybrid compounds, SNAr reaction, regioselective synthesis, antitumor activity.

Язык публикации: английский

DOI: 10.1016/j.mencom.2021.11.032



© МИАН, 2025